novo nordisk semaglutide nash Nordisk's Hits Phase III Marks In ESSENCE - Semaglutide in Metabolic
Description
Individually tailored weight management plans are developed using detailed lab work, clinical insight, and patient goals
Andrade, S
Griauzde DH, Ibrahim AM, Fisher N, Stricklen A, Ross R, Ghaferi AA
doi: 10.3389/fphar.2025.1529652
The study demonstrated that pharmacist-led interventions such as medication reviews, adherence counselling, and lifestyle education contributed to glycemic control (Alsuwayni and Alhossan 2020)
